Cargando…
Reduced binding activity of vaccine serum to omicron receptor-binding domain
Coronavirus disease 2019 (COVID-19) vaccination regimens contribute to limiting the spread of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). However, the emergence and rapid transmission of the SARS-CoV-2 variant Omicron raise a concern about the efficacy of the current vaccination st...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369000/ https://www.ncbi.nlm.nih.gov/pubmed/35967350 http://dx.doi.org/10.3389/fimmu.2022.960195 |
_version_ | 1784766320778149888 |
---|---|
author | Li, Mingzhi Weng, Shiqi Wang, Quansheng Yang, Zibing Wang, Xiaoling Yin, Yanjun Zhou, Qiuxiang Zhang, Lirong Tao, Feifei Li, Yihan Jia, Mengle Yang, Lingdi Xin, Xiu Li, Hanguang Kang, Lumei Wang, Yu Wang, Ting Li, Sha Kong, Lingbao |
author_facet | Li, Mingzhi Weng, Shiqi Wang, Quansheng Yang, Zibing Wang, Xiaoling Yin, Yanjun Zhou, Qiuxiang Zhang, Lirong Tao, Feifei Li, Yihan Jia, Mengle Yang, Lingdi Xin, Xiu Li, Hanguang Kang, Lumei Wang, Yu Wang, Ting Li, Sha Kong, Lingbao |
author_sort | Li, Mingzhi |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) vaccination regimens contribute to limiting the spread of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). However, the emergence and rapid transmission of the SARS-CoV-2 variant Omicron raise a concern about the efficacy of the current vaccination strategy. Here, we expressed monomeric and dimeric receptor-binding domains (RBDs) of the spike protein of prototype SARS-CoV-2 and Omicron variant in E. coli and investigated the reactivity of anti-sera from Chinese subjects immunized with SARS-CoV-2 vaccines to these recombinant RBDs. In 106 human blood samples collected from 91 participants from Jiangxi, China, 26 sera were identified to be positive for SARS-CoV-2 spike protein antibodies by lateral flow dipstick (LFD) assays, which were enriched in the ones collected from day 7 to 1 month post-boost (87.0%) compared to those harvested within 1 week post-boost (23.8%) (P < 0.0001). A higher positive ratio was observed in the child group (40.8%) than adults (13.6%) (P = 0.0073). ELISA results showed that the binding activity of anti-SARS-CoV-2 antibody-positive sera to Omicron RBDs dropped by 1.48- to 2.07-fold compared to its homogeneous recombinant RBDs. Thus, our data indicate that current SARS-CoV-2 vaccines provide restricted humoral protection against the Omicron variant. |
format | Online Article Text |
id | pubmed-9369000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93690002022-08-12 Reduced binding activity of vaccine serum to omicron receptor-binding domain Li, Mingzhi Weng, Shiqi Wang, Quansheng Yang, Zibing Wang, Xiaoling Yin, Yanjun Zhou, Qiuxiang Zhang, Lirong Tao, Feifei Li, Yihan Jia, Mengle Yang, Lingdi Xin, Xiu Li, Hanguang Kang, Lumei Wang, Yu Wang, Ting Li, Sha Kong, Lingbao Front Immunol Immunology Coronavirus disease 2019 (COVID-19) vaccination regimens contribute to limiting the spread of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). However, the emergence and rapid transmission of the SARS-CoV-2 variant Omicron raise a concern about the efficacy of the current vaccination strategy. Here, we expressed monomeric and dimeric receptor-binding domains (RBDs) of the spike protein of prototype SARS-CoV-2 and Omicron variant in E. coli and investigated the reactivity of anti-sera from Chinese subjects immunized with SARS-CoV-2 vaccines to these recombinant RBDs. In 106 human blood samples collected from 91 participants from Jiangxi, China, 26 sera were identified to be positive for SARS-CoV-2 spike protein antibodies by lateral flow dipstick (LFD) assays, which were enriched in the ones collected from day 7 to 1 month post-boost (87.0%) compared to those harvested within 1 week post-boost (23.8%) (P < 0.0001). A higher positive ratio was observed in the child group (40.8%) than adults (13.6%) (P = 0.0073). ELISA results showed that the binding activity of anti-SARS-CoV-2 antibody-positive sera to Omicron RBDs dropped by 1.48- to 2.07-fold compared to its homogeneous recombinant RBDs. Thus, our data indicate that current SARS-CoV-2 vaccines provide restricted humoral protection against the Omicron variant. Frontiers Media S.A. 2022-07-28 /pmc/articles/PMC9369000/ /pubmed/35967350 http://dx.doi.org/10.3389/fimmu.2022.960195 Text en Copyright © 2022 Li, Weng, Wang, Yang, Wang, Yin, Zhou, Zhang, Tao, Li, Jia, Yang, Xin, Li, Kang, Wang, Wang, Li and Kong https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Li, Mingzhi Weng, Shiqi Wang, Quansheng Yang, Zibing Wang, Xiaoling Yin, Yanjun Zhou, Qiuxiang Zhang, Lirong Tao, Feifei Li, Yihan Jia, Mengle Yang, Lingdi Xin, Xiu Li, Hanguang Kang, Lumei Wang, Yu Wang, Ting Li, Sha Kong, Lingbao Reduced binding activity of vaccine serum to omicron receptor-binding domain |
title | Reduced binding activity of vaccine serum to omicron receptor-binding domain |
title_full | Reduced binding activity of vaccine serum to omicron receptor-binding domain |
title_fullStr | Reduced binding activity of vaccine serum to omicron receptor-binding domain |
title_full_unstemmed | Reduced binding activity of vaccine serum to omicron receptor-binding domain |
title_short | Reduced binding activity of vaccine serum to omicron receptor-binding domain |
title_sort | reduced binding activity of vaccine serum to omicron receptor-binding domain |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369000/ https://www.ncbi.nlm.nih.gov/pubmed/35967350 http://dx.doi.org/10.3389/fimmu.2022.960195 |
work_keys_str_mv | AT limingzhi reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT wengshiqi reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT wangquansheng reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT yangzibing reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT wangxiaoling reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT yinyanjun reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT zhouqiuxiang reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT zhanglirong reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT taofeifei reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT liyihan reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT jiamengle reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT yanglingdi reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT xinxiu reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT lihanguang reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT kanglumei reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT wangyu reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT wangting reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT lisha reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain AT konglingbao reducedbindingactivityofvaccineserumtoomicronreceptorbindingdomain |